News
PPBT
0.7127
+2.55%
0.0177
Weekly Report: what happened at PPBT last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at PPBT last week (0212-0216)?
Weekly Report · 02/19 09:49
Weekly Report: what happened at PPBT last week (0205-0209)?
Weekly Report · 02/12 09:45
Weekly Report: what happened at PPBT last week (0129-0202)?
Weekly Report · 02/05 09:48
Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Sanofi (OtherSNYNF)
2 analysts have maintained Buy ratings on Purple Biotech and Sanofi. Purple Bi biotech has a price target of $10.00. Barclays maintained a Buy rating on Sanofi today. The company's shares closed at $101.00 on Monday. The analyst consensus is a Moderate Buy for both companies.
TipRanks · 02/01 15:40
Purple Biotech stock climbs 9% on Phase 2 study update
Shares of Purple Biotech stock climbs 9% on Phase 2 study update. The company said it has determined the recommended dose of its oncology drug candidate NT219 for its upcoming study. The Israeli drug developer plans to use 100mg/kg for the treatment of head and neck cancer.
Seeking Alpha · 02/01 15:14
Purple Biotech Says Determined 100Mg/Kg Is The Recommended Phase 2 Dose For NT219 In Combination With Cetuximab In The Treatment Of Head And Neck Cancer Based On Its Phase 1/2 Dose Escalation Study
Benzinga · 02/01 12:38
Weekly Report: what happened at PPBT last week (0122-0126)?
Weekly Report · 01/29 09:44
Purple Biotech Ltd: Report of foreign issuer
Press release · 01/26 22:26
Weekly Report: what happened at PPBT last week (0115-0119)?
Weekly Report · 01/22 09:46
Weekly Report: what happened at PPBT last week (0108-0112)?
Weekly Report · 01/15 09:45
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 6.7% to $0.26 during Wednesday's after-market session. Semler Scientific shares rose 5.99% and China Pharma Holding (AMEX:CPHI) stock rose by 5.82%. Losers 180 Life Sciences (NASdaq:ATNF) shares fell 18.2% and Alpha Tau Medical stock fell 7.28%.
Benzinga · 01/10 21:31
Weekly Report: what happened at PPBT last week (0101-0105)?
Weekly Report · 01/08 09:46
Weekly Report: what happened at PPBT last week (1225-1229)?
Weekly Report · 01/01 09:44
Weekly Report: what happened at PPBT last week (1218-1222)?
Weekly Report · 12/25/2023 09:48
Purple Biotech Ltd: Report of foreign issuer
Press release · 12/20/2023 14:28
Weekly Report: what happened at PPBT last week (1211-1215)?
Weekly Report · 12/18/2023 09:50
Purple Biotech Ltd: Report of foreign issuer
Press release · 12/14/2023 13:34
PPBT, ANY and FLJ among pre-market losers
PPBT, ANY and FLJ among pre-market losers. Cogent Biosciences (COGT) -31%. Announces positive data from ongoing phase 2 trial evaluating Bezuclastinib in patients. Bitcoin extends loses as bitcoin extends loses.
Seeking Alpha · 12/11/2023 13:27
12 Health Care Stocks Moving In Monday's Pre-Market Session
Pasithea Therapeutics (NASDAQ:KTTA) shares moved upwards by 86.6% to $0.56 during Monday's pre-market session. Assure Hldgs stock increased by 65.37% and Poseida Therapeutic shares rose by 25.94% during the same period. Losers include Cogent Biosciences and X4 Pharmaceuticals.
Benzinga · 12/11/2023 13:06
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.